These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Clinical-CT mismatch defined NIHSS ≥ 8 and CT-ASPECTS ≥ 9 as a reliable marker of candidacy for intravenous thrombolytic therapy in acute ischemic stroke. Wu HM; Lee IH; Luo CB; Chung CP; Lin YY PLoS One; 2021; 16(4):e0251077. PubMed ID: 33930103 [TBL] [Abstract][Full Text] [Related]
13. Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Campbell BC; Christensen S; Levi CR; Desmond PM; Donnan GA; Davis SM; Parsons MW Stroke; 2012 Oct; 43(10):2648-53. PubMed ID: 22858726 [TBL] [Abstract][Full Text] [Related]
14. Penumbra and re-canalization acute computed tomography in ischemic stroke evaluation: PRACTISE study protocol. El-Tawil S; Wardlaw J; Ford I; Mair G; Robinson T; Kalra L; Muir KW Int J Stroke; 2017 Aug; 12(6):671-678. PubMed ID: 28730951 [TBL] [Abstract][Full Text] [Related]
15. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator. Ong CT; Wong YS; Wu CS; Su YH Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721 [TBL] [Abstract][Full Text] [Related]
16. Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset. Han MK; Kim SH; Ko SB; Paik NJ; Kwon OK; Lee YS; Oh CW; Kim JH; Park SH; Bae HJ Neurocrit Care; 2008; 8(3):353-9. PubMed ID: 18340411 [TBL] [Abstract][Full Text] [Related]
18. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study. Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. Lee KH; Lee SJ; Cho SJ; Na DG; Byun HS; Kim YB; Song HJ; Jin IS; Chung CS Arch Neurol; 2000 Jul; 57(7):1000-8. PubMed ID: 10891982 [TBL] [Abstract][Full Text] [Related]
20. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]